Protalix Biotherapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protalix Biotherapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $5.9k | 2.3k | 2.56 |
| 2024-12-31 | $1.2k | 632 | 1.88 |
| 2024-06-30 | $1.3k | 1.3k | 1.00 |
| 2024-03-31 | $16k | 13k | 1.26 |
| 2023-12-31 | $21k | 12k | 1.79 |
| 2023-09-30 | $3.2k | 1.9k | 1.67 |